Fennec Pharmaceuticals Inc – Quartals-Cashflow (NASDAQ:FENC) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 44.95 M46.4 M44.88 M49.26 M70.55 M Gesamtverbindlichkeiten 50.82 M52.28 M52.34 M53.75 M35.08 M Gesamtkapital -5.87 M-5.88 M-7.46 M-4.49 M35.47 M Gesamtverbindlichkeiten und Eigenkapital 44.95 M46.4 M44.88 M49.26 M70.55 M Gesamtverschuldung 19.34 M19.35 M19.36 M19.38 M— Nettoverschuldung -7.29 M-3.32 M659 K-2.57 M—

Nachrichten

Fennec Pharmaceuticals verfehlt Q4-Prognosen deutlich – Aktie bricht vorbörslich ein

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Fennec Pharmaceuticals (NASDAQ:FENC)

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates

Certara, Inc. (CERT) Q4 Earnings Lag Estimates

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC)

City of Hope to study PEDMARK for hearing protection in testicular cancer